Paper35348441
MicroRNA miR-27a-3p accelerates cardiac hypertrophy by targeting neuro-oncological ventral antigen 1.
Li D and 3 others. Bioengineered, 2022. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. MicroRNA miR-27a-3p accelerates cardiac hypertrophy by targeting neuro-oncological ventral antigen 1. Papers, record 35348441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35348441
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- MicroRNA miR-27a-3p accelerates cardiac hypertrophy by targeting neuro-oncological ventral antigen 1.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiomegaly | Major topic |
| MicroRNAs | Major topic |
| Neuro-Oncological Ventral Antigen | Major topic |
| Angiotensin II | |
| Animals | |
| Mice | |
| Myocytes, Cardiac |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27588076 | miR-155 functions downstream of angiotensin II receptor subtype 1 and calcineurin to regulate cardiac hypertrophy. | Exp Ther Med | 2016 | https://conductscience.org/library/papers/27588076 | PubMed |
| 2 | 24448313 | Pregnancy as a cardiac stress model. | Cardiovasc Res | 2014 | https://conductscience.org/library/papers/24448313 | PubMed |
| 3 | 23099820 | Increased afterload induces pathological cardiac hypertrophy: a new in vitro model. | Basic Res Cardiol | 2012 | https://conductscience.org/library/papers/23099820 | PubMed |
| 4 | 26391641 | MicroRNA-339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1. | FEBS Lett | 2015 | https://conductscience.org/library/papers/26391641 | PubMed |
| 5 | 26673617 | NOVA1 inhibition by miR-146b-5p in the remnant tissue microenvironment defines occult residual disease after gastric cancer removal. | Oncotarget | 2016 | https://conductscience.org/library/papers/26673617 | PubMed |
| 6 | 23608998 | Reduction in left ventricular wall stress and improvement in function in failing hearts using Algisyl-LVR. | J Vis Exp | 2013 | https://conductscience.org/library/papers/23608998 | PubMed |
| 7 | 29674714 | Mechanisms of physiological and pathological cardiac hypertrophy. | Nat Rev Cardiol | 2018 | https://conductscience.org/library/papers/29674714 | PubMed |
| 8 | 26629048 | MiR-27a-3p promotes esophageal cancer cell proliferation via F-box and WD repeat domain-containing 7 (FBXW7) suppression. | Int J Clin Exp Med | 2015 | https://conductscience.org/library/papers/26629048 | PubMed |
| 9 | 24557880 | The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. | Circ Res | 2014 | https://conductscience.org/library/papers/24557880 | PubMed |
| 10 | 26922803 | Upregulated Neuro-oncological Ventral Antigen 1 (NOVA1) Expression Is Specific to Mature and Immature T- and NK-Cell Lymphomas. | J Pathol Transl Med | 2016 | https://conductscience.org/library/papers/26922803 | PubMed |
| 11 | 26538569 | Function and Therapeutic Potential of Noncoding RNAs in Cardiac Fibrosis. | Circ Res | 2016 | https://conductscience.org/library/papers/26538569 | PubMed |
| 12 | 23860036 | MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention. | Cell Physiol Biochem | 2013 | https://conductscience.org/library/papers/23860036 | PubMed |
| 13 | 29137318 | miR-27a-3p targeting RXRα promotes colorectal cancer progression by activating Wnt/β-catenin pathway. | Oncotarget | 2017 | https://conductscience.org/library/papers/29137318 | PubMed |
| 14 | 21880653 | Physiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms. | Heart | 2012 | https://conductscience.org/library/papers/21880653 | PubMed |
| 15 | 30680929 | Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway. | J Cell Mol Med | 2019 | https://conductscience.org/library/papers/30680929 | PubMed |
| 16 | 26105073 | A large-scale functional screen identifies Nova1 and Ncoa3 as regulators of neuronal miRNA function. | EMBO J | 2015 | https://conductscience.org/library/papers/26105073 | PubMed |
| 17 | 30195764 | miR-217 Promotes Cardiac Hypertrophy and Dysfunction by Targeting PTEN. | Mol Ther Nucleic Acids | 2018 | https://conductscience.org/library/papers/30195764 | PubMed |
| 18 | 24161319 | Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy. | J Am Coll Cardiol | 2014 | https://conductscience.org/library/papers/24161319 | PubMed |
| 19 | 29068585 | MicroRNA in cardiovascular biology and disease. | Adv Clin Exp Med | 2017 | https://conductscience.org/library/papers/29068585 | PubMed |
| 20 | 23258295 | Molecular basis of physiological heart growth: fundamental concepts and new players. | Nat Rev Mol Cell Biol | 2013 | https://conductscience.org/library/papers/23258295 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42710844 | Sex-dependent epigenomic and transcriptomic reprogramming links maternal obesity to cardiac remodeling in adult offspring. | Am J Physiol Heart Circ Physiol | 2026 | https://conductscience.org/library/papers/42710844 | PubMed |
| 40771931 | MicroRNA: unveiling novel mechanistic and theranostic pathways in diabetic cardiomyopathy. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40771931 | PubMed |
| 40214506 | Circulating Non-Coding RNAs as Indicators of Fibrosis and Heart Failure Severity. | Cells | 2025 | https://conductscience.org/library/papers/40214506 | PubMed |
| 39850481 | Extracellular vesicular microRNAs and cardiac hypertrophy. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/39850481 | PubMed |
| 37103045 | Noncoding RNAs as Key Regulators for Cardiac Development and Cardiovascular Diseases. | J Cardiovasc Dev Dis | 2023 | https://conductscience.org/library/papers/37103045 | PubMed |
| 36497112 | Induction of Cardiac Pathology: Endogenous versus Exogenous Nrf2 Upregulation. | Cells | 2022 | https://conductscience.org/library/papers/36497112 | PubMed |
| 36078109 | Monoamine Oxidase-Dependent Pro-Survival Signaling in Diabetic Hearts Is Mediated by miRNAs. | Cells | 2022 | https://conductscience.org/library/papers/36078109 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BTG2 | 7832 | PubTator's text mining | https://conductscience.org/library/genes/7832 | NCBI Gene |
| FBXW7 | 55294 | PubTator's text mining | https://conductscience.org/library/genes/55294 | NCBI Gene |
| GAPDH | 2597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| MIR150 | 406942 | PubTator's text mining | https://conductscience.org/library/genes/406942 | NCBI Gene |
| NOVA1 | 4857 | PubTator's text mining | https://conductscience.org/library/genes/4857 | NCBI Gene |
| NPPA | 4878 | PubTator's text mining | https://conductscience.org/library/genes/4878 | NCBI Gene |
| NPPB | 4879 | PubTator's text mining | https://conductscience.org/library/genes/4879 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35348441
GET https://conductscience.org/api/papers/v1/35348441/references?page=2